In ₹ Crore except Per Share 12 Months Ending | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|
| Total Income | — | — | — | 1,20,360.7 | |
| Expenses | |||||
| Total Expenses | — | — | — | 1,16,999.5 | |
| Profit | |||||
| + Current Tax | — | — | — | 161.5 | |
| Revenue Detail — as filed | |||||
| + Investment Income | — | — | — | 1,286.1 | |
| + Income from Investments (net) | — | — | — | 15,514.0 | |
| Expense Detail — as filed | |||||
| + Advertisement & Publicity | — | — | — | 248.7 | |
| + Employee Remuneration & Welfare | — | — | — | 3,341.2 | |
| + Commission | — | — | — | 4,639.2 | |
| + Commission (net) | — | — | — | 4,639.2 | |
| + Provision — Diminution in Investments | — | — | — | 20.0 | |
| + Provision — Doubtful Debts & Write-offs | — | — | — | 0.8 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||
| Profit / (Loss) before Tax | — | — | — | 2,672.4 | |
| + Current Taxes | — | — | — | 71.5 | |
| + Provision for Tax | — | — | — | 161.5 | |
| + Provisions for Taxes | — | — | — | 71.5 | |
| PAT before Extraordinary Items | — | — | — | 2,600.9 | |
| PAT after Extraordinary Items | — | — | — | 2,600.9 | |
| Profit Carried to Balance Sheet | — | — | — | 70,400.8 | |
| Per Share — as-filed variants | |||||
| Basic & Diluted EPS before Extraordinary (not annualised) | — | — | — | 25.93 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | — | — | — | 25.92 | |
| Appropriations & Transfers | |||||
| Reserves & Surplus excl. Revaluation Reserve | — | — | — | 71,349.5 | |
| + Interim Dividend | — | — | — | 0.0 | |
| Insurance — Revenue Account (Policyholders') | |||||
| + Gross Premium Income | — | — | — | 1,04,761.9 | |
| + Net Premium Income | — | — | — | 1,02,855.6 | |
| + First-year Premium | — | — | — | 23,256.5 | |
| + Renewal Premium | — | — | — | 60,570.3 | |
| + Single Premium | — | — | — | 20,935.1 | |
| + Commission — First-year Premium | — | — | — | 2,909.6 | |
| + Commission — Renewal Premium | — | — | — | 1,479.9 | |
| + Commission — Single Premium | — | — | — | 249.7 | |
| + Expenses of Management | — | — | — | 11,371.0 | |
| + Operating Expenses — Insurance Business | — | — | — | 6,731.8 | |
| + Expenses — Non-insurance | — | — | — | 29.1 | |
| + Benefits Paid (net) | — | — | — | 57,331.8 | |
| + Change in Actuarial Liability | — | — | — | 47,849.8 | |
| + Bonus Allocated to Policyholders | — | — | — | 2,060.5 | |
| + Interim Bonus Paid | — | — | — | 30.2 | |
| + Terminal Bonus Paid | — | — | — | 717.6 | |
| + GST on Linked Charges | — | — | — | 264.6 | |
| Surplus in the Revenue Account | — | — | — | 3,361.2 | |
| Net Surplus / (Deficit) | — | — | — | 3,361.2 | |
| + Funds for Future Appropriation | — | — | — | 64.8 | |
| + Policyholders' Liabilities to Shareholders' Fund | — | — | — | 25.9 | |
| Insurance — Shareholders' Account | |||||
| + Income under Shareholders' Account | — | — | — | 1,286.3 | |
| + Shareholders' Account Income | — | — | — | 4,582.7 | |
| + Shareholders' Account Expenses | — | — | — | 1,910.3 | |
| + Shareholders' Provision — Diminution in Investments | — | — | — | 7.2 | |
| + Transfer from Policyholders' Account | — | — | — | 3,296.4 | |
| + Transfer of Funds to Policyholders' Account | — | — | — | 1,873.9 | |
| + Transferred to Shareholders' Account | — | — | — | 3,296.4 | |
| Shareholders' Fund — with Unrealised Gains | — | — | — | 0.2 | |
| Shareholders' Fund — without Unrealised Gains | — | — | — | 0.1 | |
| Insurance — Fund NPAs | |||||
| + Linked Non-participating — with Unrealised Gains | — | — | — | 0.0 | |
| + Linked Non-participating — without Unrealised Gains | — | — | — | 0.0 | |
| + Non-linked Participating — with Unrealised Gains | — | — | — | 0.0 | |
| + Non-linked Participating — without Unrealised Gains | — | — | — | 0.0 | |
| + Non-linked Non-participating — with Unrealised Gains | — | — | — | 0.0 | |
| + Non-linked Non-participating — without Unrealised Gains | — | — | — | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||
| Solvency Ratio | — | — | — | 2.02 | |
| Conservation Ratio | — | — | — | 0.90 | |
| Expenses of Management Ratio | — | — | — | 0.12 | |
| Persistency — 13th Month | — | — | — | 0.87 | |
| Persistency — 25th Month | — | — | — | 0.79 | |
| Persistency — 37th Month | — | — | — | 0.73 | |
| Persistency — 49th Month | — | — | — | 0.70 | |
| Persistency — 61st Month | — | — | — | 0.61 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||
| Investor Complaints — Received | — | — | — | 15.00 | |
| Investor Complaints — Disposed | — | — | — | 15.00 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||
| Other Operating Expenses | — | — | — | 3,141.9 | |